Posts Tagged ‘ thinkalchemy’s press release

Looking for DUI Defense Lawyer in Las Vegas? Finding an Experienced and Ethical Attorney is Vital to your Case! Paul J. Adras is That Attorney.

Tourism PR News and Hospitality and Tourism News Articles picks up thinkAlchemy’s press release for Paul J. Adras is That Attorney on of the top ethical lawyers in Las Vegas.

After a DUI arrest in Las Vegas, most people believe the case is black and white. You were pulled over for just cause, you were legally intoxicated and read your rights. What you don’t realize is pleading “not guilty” does not mean you are denying the facts. It does mean, however, you want your rights protected every step of the way. When your freedom is on the line, nothing is more important than having your rights protected. The Law Offices of Paul J. Adras know how to do just that. He knows which police records to subpeona so he can understand the strength and weaknesses of the state’s case against you. He will analyze the case and find out if the your traffic stop or sobriety tests were legitimate. And he’ll get started with your first phone call. Office (702) 463-4200

Visit Paul’s site here:

Contact Michael Glock to discuss the benefits of releasing your product or service news with nationwide PR releases from thinkalchemy.

Email: Michael Glock

310- 577 2380

Marina del Rey

Have You or a Loved One Suffered from a Stroke or Heart Attack While on Birth Control? You Need an Experienced Defective Drug Lawyer!

Science and Research News picks up thinkalchemy’s press release for The Law Offices of Sybil Shainwald. As does NewsBlaze and Medical PR News and Womens News Articles.

NEW YORK, NY, February 03, 2010 /thinkalchemy PR/ — Sybil Shainwald, the founder of the Law Offices of Sybil Shainwald, pioneered DES legislation and has been given numerous awards for this exceptional work. Ms. Shainwald has litigated mass tort cases involving drugs that have inflicted harm on women or their children and their loved ones. DES is a synthetic hormone that was manufactured between 1947 and 1971 to help avoid miscarriage. Doctors reported a link between mothers who took DES and rare clear-celled cervical and vaginal cancers and their daughters as well as infertility and possible testicular cancers in their sons. DES was also linked to breast cancer in the mothers.

Read the full press release here in Pharmaceutical Industry Today.

Contact Michael Glock to discuss the benefits of releasing your product or service news with nationwide PR releases from thinkalchemy.

Email: Michael Glock

31- 577 2380

Marina del Rey